CN Stock MarketDetailed Quotes

600267 Zhejiang Hisun Pharmaceutical

Watchlist
  • 8.33
  • -0.12-1.42%
Market Closed Nov 1 15:00 CST
10.06BMarket Cap-490000P/E (TTM)

Zhejiang Hisun Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-5.21%1.48B
7.49%1.44B
-0.74%1.57B
13.43%1.59B
23.78%1.57B
2.48%1.34B
1.50%1.58B
7.95%1.4B
-18.00%1.26B
17.97%1.31B
Transactional financial assets
----
----
----
--292.62K
----
----
----
----
-59.56%684K
75.95%1.75M
Notes receivable and accounts receivable
-24.26%1.94B
-23.51%2.04B
-20.82%1.96B
-21.92%1.92B
9.21%2.56B
23.37%2.67B
13.12%2.48B
17.31%2.46B
8.40%2.35B
3.79%2.17B
-Notes receivable
----
----
----
----
--46.79M
-22.21%8.3M
1,362.78%4.39M
----
----
240.15%10.67M
-Accounts receivable
-22.85%1.94B
-23.27%2.04B
-20.68%1.96B
-21.92%1.92B
7.22%2.52B
23.59%2.66B
12.94%2.47B
17.31%2.46B
8.40%2.35B
3.44%2.16B
Other receivables (including interest and dividends)
31.89%280.92M
-4.81%221.03M
-24.88%203.48M
-18.46%203.51M
-59.57%212.99M
-41.03%232.2M
-30.45%270.88M
-39.72%249.57M
64.20%526.77M
26.07%393.74M
-Accrued interest receivable
----
----
----
----
----
--1.18M
----
----
----
----
-Other receivable
----
-4.32%221.03M
----
----
----
-41.33%231.02M
----
-39.72%249.57M
----
26.07%393.74M
Advance payment
-20.38%156.94M
-6.74%204.58M
-0.97%242.42M
-16.01%214.09M
-18.47%197.11M
-14.62%219.36M
-7.68%244.78M
12.87%254.9M
8.51%241.77M
50.38%256.94M
Inventories
-7.84%1.73B
-0.93%1.75B
-3.66%1.83B
2.23%1.96B
14.67%1.88B
7.90%1.77B
5.06%1.9B
-5.38%1.91B
-23.73%1.64B
-30.23%1.64B
Receivable financing
-18.37%132.24M
19.40%227.19M
9.42%256.31M
53.07%148.96M
103.27%162M
24.31%190.28M
34.58%234.25M
-33.37%97.32M
-57.12%79.7M
-32.41%153.06M
Other current assets
67.77%59.07M
486.70%214.18M
741.37%313.25M
745.07%331.38M
8.76%35.21M
-65.35%36.51M
-75.15%37.23M
-76.01%39.21M
-81.37%32.37M
-49.83%105.36M
Total current assets
-12.53%5.78B
-5.50%6.11B
-5.46%6.37B
-0.78%6.36B
7.88%6.61B
7.23%6.46B
3.16%6.74B
0.71%6.41B
-9.30%6.13B
-6.84%6.03B
Non Current assets
Other non-current financial assets
-0.54%20.03M
0.00%20.09M
-0.18%20.18M
-0.07%20.2M
-0.32%20.14M
-0.58%20.09M
0.07%20.22M
0.07%20.22M
-49.71%20.2M
-49.71%20.2M
Investment real estate
-7.65%95.21M
-7.56%96.79M
-7.45%98.37M
-7.03%99.24M
-2.87%103.09M
-2.86%104.71M
27.12%106.29M
25.80%106.75M
26.70%106.14M
48.09%107.79M
Long-term equity investment
9.96%1.46B
-0.09%1.43B
-0.73%1.44B
-4.61%1.39B
-4.99%1.32B
0.21%1.43B
5.35%1.45B
8.41%1.46B
5.10%1.39B
6.22%1.43B
Fixed assets
----
0.03%7.43B
----
----
----
-5.79%7.43B
----
-4.30%7.81B
----
1.61%7.89B
Constru in process
----
-68.35%387.21M
----
----
----
-19.44%1.22B
----
-19.26%1.24B
----
-34.44%1.52B
Intangible assets
-19.70%962.68M
-15.77%1.04B
-21.40%1.02B
-19.72%1.07B
-12.16%1.2B
-13.14%1.23B
-10.51%1.3B
-5.80%1.34B
12.98%1.36B
34.81%1.42B
Development expenditure
-75.08%46.21M
-9.20%168.18M
-9.07%167.7M
-8.72%167.7M
1.65%185.41M
4.04%185.23M
5.24%184.43M
5.63%183.72M
6.00%182.39M
-41.64%178.04M
Long deferred expense
-61.53%6.12M
-40.43%6.86M
-38.02%7.66M
-20.23%8.56M
59.36%15.9M
19.80%11.51M
5.64%12.36M
-18.90%10.73M
0.74%9.98M
-16.21%9.61M
Deferred tax assets
31.79%152.8M
53.48%174.48M
94.97%183.03M
86.78%179.62M
15.38%115.94M
8.44%113.68M
-19.11%93.88M
-18.90%96.17M
-39.88%100.49M
-45.01%104.83M
Usufruct assets
58.48%66.37M
-11.58%39.66M
-12.68%40.97M
-8.11%38.91M
-2.48%41.88M
-1.62%44.85M
0.82%46.92M
-10.42%42.34M
152.23%42.95M
141.44%45.59M
Other non current assets
-54.34%25.15M
-61.50%21.03M
15.95%59.54M
14.94%59.78M
7.47%55.09M
-14.54%54.63M
-19.34%51.35M
-15.89%52.01M
-72.61%51.26M
-68.33%63.93M
Total non current assets
-9.08%10.47B
-8.75%10.82B
-8.59%11.06B
-9.01%11.25B
-7.17%11.52B
-7.28%11.85B
-6.46%12.1B
-4.93%12.37B
-6.01%12.41B
-4.70%12.78B
Total assets
-10.34%16.26B
-7.60%16.93B
-7.47%17.43B
-6.20%17.61B
-2.19%18.13B
-2.63%18.32B
-3.23%18.84B
-3.08%18.78B
-7.12%18.54B
-5.40%18.81B
Liabilities
Current liabilities
Short term loan
-5.00%2.48B
-2.97%2.65B
-1.86%2.64B
-10.10%2.16B
-4.52%2.61B
-26.89%2.73B
-36.41%2.69B
-39.84%2.4B
-33.85%2.73B
-17.85%3.74B
Transactional financial liabilities
----
----
----
----
-99.82%69.77K
-54.71%1.25M
----
43.20%1.55M
5,236.10%37.89M
64.83%2.77M
Notes payable and accounts payable
-16.59%1B
0.79%1.18B
7.54%1.38B
-14.12%1.31B
-3.62%1.2B
-5.11%1.17B
-2.44%1.28B
15.87%1.53B
-11.58%1.25B
-12.81%1.24B
-Notes payable
-24.14%294.48M
10.54%429.64M
-1.77%518.2M
-10.71%445.77M
17.19%388.19M
0.38%388.67M
38.40%527.51M
59.93%499.22M
4.11%331.24M
3.61%387.21M
-Accounts payable
-12.99%709.18M
-4.04%753.28M
14.02%863M
-15.77%868.42M
-11.13%815.09M
-7.62%785M
-19.08%756.88M
2.24%1.03B
-16.14%917.2M
-18.68%849.71M
Contract liabilities
36.95%116.28M
5.35%104.52M
-31.93%109.48M
-10.58%106.46M
-47.69%84.9M
-60.34%99.21M
-44.78%160.83M
-55.65%119.05M
-46.72%162.31M
-14.29%250.13M
Advance receipts
--40K
--40K
--40K
--40K
----
----
----
----
----
----
Salaries payable
28.79%393.53M
11.73%330.59M
6.67%258.68M
-11.56%353.8M
-13.22%305.57M
-3.42%295.87M
6.12%242.51M
-2.32%400.07M
4.05%352.14M
9.28%306.36M
Taxs payable
-10.16%142.89M
-17.83%121.68M
-34.56%96.87M
-36.54%140.94M
-15.50%159.05M
46.88%148.09M
10.88%148.02M
7.47%222.09M
-15.33%188.23M
-43.02%100.82M
Other payable (including interest and dividends)
-13.40%1.22B
6.27%1.46B
-0.91%1.32B
12.95%1.37B
17.86%1.41B
13.77%1.38B
14.84%1.33B
-2.13%1.21B
-1.40%1.2B
29.09%1.21B
-Other payable
----
6.27%1.46B
----
----
----
13.77%1.38B
----
-2.13%1.21B
----
29.09%1.21B
Non current liabilities due within one year
9.63%883.11M
-5.95%847.64M
27.99%1.09B
77.85%1.14B
18.78%805.56M
17.58%901.24M
19.57%850.46M
-24.19%639.54M
43.18%678.18M
48.46%766.51M
Other current liabilities
40.40%6.89M
4,635.21%308.72M
-3.19%308.47M
-98.92%6.61M
-99.20%4.9M
-97.88%6.52M
-38.53%318.63M
19.83%610.78M
17.74%611.82M
-40.14%307.69M
Total current liabilities
-5.11%6.25B
4.09%7.01B
2.51%7.21B
-7.70%6.58B
-8.67%6.58B
-14.94%6.74B
-18.21%7.03B
-18.80%7.13B
-16.33%7.21B
-8.84%7.92B
Current liabilities
Long term loan
3.75%1.27B
7.59%1.32B
-12.00%1.28B
-28.08%1.12B
-10.66%1.22B
-14.26%1.22B
0.51%1.45B
17.63%1.55B
-19.34%1.37B
-15.92%1.43B
Bonds payable
----
----
-77.77%337.72M
-16.79%1.25B
-16.79%1.24B
-16.77%1.22B
4.59%1.52B
4.59%1.5B
4.59%1.49B
4.59%1.47B
Estimate liabilities
----
----
--74.08M
--74.08M
----
----
----
----
----
----
Deferred tax liabilities
-7.38%24.25M
-5.07%24.13M
58.93%28.55M
25.96%22.63M
53.39%26.18M
41.93%25.42M
-18.09%17.97M
-13.32%17.97M
-25.40%17.07M
-33.08%17.91M
Long term deferred income
-12.39%164.77M
-11.44%174.48M
-10.61%178.84M
-10.23%185.96M
-11.52%188.06M
-11.89%197.01M
-1.61%200.06M
-4.22%207.15M
-6.61%212.56M
-6.15%223.59M
Lease liabilities
59.42%54.41M
-2.30%34.82M
-7.82%34.04M
-9.98%29.15M
-8.36%34.13M
-8.37%35.64M
-5.80%36.92M
-13.79%32.38M
303.93%37.24M
235.31%38.9M
Other non current liabilities
----
----
----
----
----
----
----
----
-56.57%211.12M
-68.07%211.12M
Total non current liabilities
-44.13%1.51B
-42.68%1.55B
-40.15%1.93B
-19.14%2.68B
-18.75%2.71B
-20.17%2.71B
-4.35%3.23B
2.18%3.31B
-13.74%3.34B
-16.14%3.39B
Total liabilities
-16.49%7.76B
-9.31%8.56B
-10.91%9.14B
-11.33%9.26B
-11.86%9.29B
-16.51%9.44B
-14.30%10.26B
-13.14%10.45B
-15.53%10.54B
-11.15%11.31B
Shareholders equity
Paid-in capital
0.00%1.21B
-0.14%1.21B
2.33%1.21B
0.81%1.21B
0.81%1.21B
0.95%1.21B
-1.52%1.18B
0.18%1.2B
0.17%1.2B
2.51%1.2B
Other equity instruments
----
----
-78.75%91.03M
-20.41%340.9M
-20.41%340.9M
-20.41%340.9M
0.00%428.33M
0.00%428.33M
0.00%428.33M
0.00%428.33M
Capital reserve funds
1.90%4.36B
-0.27%4.36B
9.09%4.35B
4.40%4.35B
8.05%4.28B
22.86%4.37B
12.48%3.99B
18.58%4.16B
14.76%3.96B
10.10%3.55B
Surplus reserve funds
7.35%554.12M
7.35%554.12M
7.35%554.12M
7.34%554.12M
11.06%516.2M
11.06%516.2M
11.06%516.2M
11.06%516.21M
15.72%464.81M
15.72%464.81M
Retained profit
-2.28%2.5B
-3.97%2.42B
-12.34%2.23B
-14.28%1.98B
15.86%2.56B
14.76%2.52B
16.94%2.54B
13.60%2.31B
4.99%2.21B
17.67%2.19B
Less:Treasury stock
10.92%375.6M
22.17%429.31M
14.80%400.03M
-37.92%341.15M
-35.95%338.62M
-7.71%351.4M
-3.48%348.47M
62.72%549.56M
121.09%528.71M
--380.75M
Other composite income
-9.89%11.66M
-20.94%11.09M
20.94%11.45M
12.08%12.17M
-0.14%12.94M
111.06%14.03M
2,111.79%9.47M
92.11%10.86M
-28.85%12.96M
-84.14%6.65M
Shareholders equity without minority interests
-3.71%8.25B
-5.77%8.12B
-3.28%8.04B
0.28%8.1B
10.76%8.57B
15.38%8.61B
11.62%8.32B
10.62%8.08B
5.22%7.74B
4.65%7.47B
Minority interests
-9.27%242.51M
-6.37%246.31M
-5.82%245.3M
-1.46%247.44M
4.61%267.28M
570.52%263.06M
504.15%260.46M
494.63%251.1M
107.59%255.5M
57.29%39.23M
Total shareholder equity
-3.88%8.5B
-5.79%8.36B
-3.36%8.29B
0.23%8.35B
10.56%8.84B
18.28%8.88B
14.45%8.58B
13.41%8.33B
6.91%7.99B
4.84%7.5B
Total liabilityies and equity
-10.34%16.26B
-7.60%16.93B
-7.47%17.43B
-6.20%17.61B
-2.19%18.13B
-2.63%18.32B
-3.23%18.84B
-3.08%18.78B
-7.12%18.54B
-5.40%18.81B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion with explanatory notes
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -5.21%1.48B7.49%1.44B-0.74%1.57B13.43%1.59B23.78%1.57B2.48%1.34B1.50%1.58B7.95%1.4B-18.00%1.26B17.97%1.31B
Transactional financial assets --------------292.62K-----------------59.56%684K75.95%1.75M
Notes receivable and accounts receivable -24.26%1.94B-23.51%2.04B-20.82%1.96B-21.92%1.92B9.21%2.56B23.37%2.67B13.12%2.48B17.31%2.46B8.40%2.35B3.79%2.17B
-Notes receivable ------------------46.79M-22.21%8.3M1,362.78%4.39M--------240.15%10.67M
-Accounts receivable -22.85%1.94B-23.27%2.04B-20.68%1.96B-21.92%1.92B7.22%2.52B23.59%2.66B12.94%2.47B17.31%2.46B8.40%2.35B3.44%2.16B
Other receivables (including interest and dividends) 31.89%280.92M-4.81%221.03M-24.88%203.48M-18.46%203.51M-59.57%212.99M-41.03%232.2M-30.45%270.88M-39.72%249.57M64.20%526.77M26.07%393.74M
-Accrued interest receivable ----------------------1.18M----------------
-Other receivable -----4.32%221.03M-------------41.33%231.02M-----39.72%249.57M----26.07%393.74M
Advance payment -20.38%156.94M-6.74%204.58M-0.97%242.42M-16.01%214.09M-18.47%197.11M-14.62%219.36M-7.68%244.78M12.87%254.9M8.51%241.77M50.38%256.94M
Inventories -7.84%1.73B-0.93%1.75B-3.66%1.83B2.23%1.96B14.67%1.88B7.90%1.77B5.06%1.9B-5.38%1.91B-23.73%1.64B-30.23%1.64B
Receivable financing -18.37%132.24M19.40%227.19M9.42%256.31M53.07%148.96M103.27%162M24.31%190.28M34.58%234.25M-33.37%97.32M-57.12%79.7M-32.41%153.06M
Other current assets 67.77%59.07M486.70%214.18M741.37%313.25M745.07%331.38M8.76%35.21M-65.35%36.51M-75.15%37.23M-76.01%39.21M-81.37%32.37M-49.83%105.36M
Total current assets -12.53%5.78B-5.50%6.11B-5.46%6.37B-0.78%6.36B7.88%6.61B7.23%6.46B3.16%6.74B0.71%6.41B-9.30%6.13B-6.84%6.03B
Non Current assets
Other non-current financial assets -0.54%20.03M0.00%20.09M-0.18%20.18M-0.07%20.2M-0.32%20.14M-0.58%20.09M0.07%20.22M0.07%20.22M-49.71%20.2M-49.71%20.2M
Investment real estate -7.65%95.21M-7.56%96.79M-7.45%98.37M-7.03%99.24M-2.87%103.09M-2.86%104.71M27.12%106.29M25.80%106.75M26.70%106.14M48.09%107.79M
Long-term equity investment 9.96%1.46B-0.09%1.43B-0.73%1.44B-4.61%1.39B-4.99%1.32B0.21%1.43B5.35%1.45B8.41%1.46B5.10%1.39B6.22%1.43B
Fixed assets ----0.03%7.43B-------------5.79%7.43B-----4.30%7.81B----1.61%7.89B
Constru in process -----68.35%387.21M-------------19.44%1.22B-----19.26%1.24B-----34.44%1.52B
Intangible assets -19.70%962.68M-15.77%1.04B-21.40%1.02B-19.72%1.07B-12.16%1.2B-13.14%1.23B-10.51%1.3B-5.80%1.34B12.98%1.36B34.81%1.42B
Development expenditure -75.08%46.21M-9.20%168.18M-9.07%167.7M-8.72%167.7M1.65%185.41M4.04%185.23M5.24%184.43M5.63%183.72M6.00%182.39M-41.64%178.04M
Long deferred expense -61.53%6.12M-40.43%6.86M-38.02%7.66M-20.23%8.56M59.36%15.9M19.80%11.51M5.64%12.36M-18.90%10.73M0.74%9.98M-16.21%9.61M
Deferred tax assets 31.79%152.8M53.48%174.48M94.97%183.03M86.78%179.62M15.38%115.94M8.44%113.68M-19.11%93.88M-18.90%96.17M-39.88%100.49M-45.01%104.83M
Usufruct assets 58.48%66.37M-11.58%39.66M-12.68%40.97M-8.11%38.91M-2.48%41.88M-1.62%44.85M0.82%46.92M-10.42%42.34M152.23%42.95M141.44%45.59M
Other non current assets -54.34%25.15M-61.50%21.03M15.95%59.54M14.94%59.78M7.47%55.09M-14.54%54.63M-19.34%51.35M-15.89%52.01M-72.61%51.26M-68.33%63.93M
Total non current assets -9.08%10.47B-8.75%10.82B-8.59%11.06B-9.01%11.25B-7.17%11.52B-7.28%11.85B-6.46%12.1B-4.93%12.37B-6.01%12.41B-4.70%12.78B
Total assets -10.34%16.26B-7.60%16.93B-7.47%17.43B-6.20%17.61B-2.19%18.13B-2.63%18.32B-3.23%18.84B-3.08%18.78B-7.12%18.54B-5.40%18.81B
Liabilities
Current liabilities
Short term loan -5.00%2.48B-2.97%2.65B-1.86%2.64B-10.10%2.16B-4.52%2.61B-26.89%2.73B-36.41%2.69B-39.84%2.4B-33.85%2.73B-17.85%3.74B
Transactional financial liabilities -----------------99.82%69.77K-54.71%1.25M----43.20%1.55M5,236.10%37.89M64.83%2.77M
Notes payable and accounts payable -16.59%1B0.79%1.18B7.54%1.38B-14.12%1.31B-3.62%1.2B-5.11%1.17B-2.44%1.28B15.87%1.53B-11.58%1.25B-12.81%1.24B
-Notes payable -24.14%294.48M10.54%429.64M-1.77%518.2M-10.71%445.77M17.19%388.19M0.38%388.67M38.40%527.51M59.93%499.22M4.11%331.24M3.61%387.21M
-Accounts payable -12.99%709.18M-4.04%753.28M14.02%863M-15.77%868.42M-11.13%815.09M-7.62%785M-19.08%756.88M2.24%1.03B-16.14%917.2M-18.68%849.71M
Contract liabilities 36.95%116.28M5.35%104.52M-31.93%109.48M-10.58%106.46M-47.69%84.9M-60.34%99.21M-44.78%160.83M-55.65%119.05M-46.72%162.31M-14.29%250.13M
Advance receipts --40K--40K--40K--40K------------------------
Salaries payable 28.79%393.53M11.73%330.59M6.67%258.68M-11.56%353.8M-13.22%305.57M-3.42%295.87M6.12%242.51M-2.32%400.07M4.05%352.14M9.28%306.36M
Taxs payable -10.16%142.89M-17.83%121.68M-34.56%96.87M-36.54%140.94M-15.50%159.05M46.88%148.09M10.88%148.02M7.47%222.09M-15.33%188.23M-43.02%100.82M
Other payable (including interest and dividends) -13.40%1.22B6.27%1.46B-0.91%1.32B12.95%1.37B17.86%1.41B13.77%1.38B14.84%1.33B-2.13%1.21B-1.40%1.2B29.09%1.21B
-Other payable ----6.27%1.46B------------13.77%1.38B-----2.13%1.21B----29.09%1.21B
Non current liabilities due within one year 9.63%883.11M-5.95%847.64M27.99%1.09B77.85%1.14B18.78%805.56M17.58%901.24M19.57%850.46M-24.19%639.54M43.18%678.18M48.46%766.51M
Other current liabilities 40.40%6.89M4,635.21%308.72M-3.19%308.47M-98.92%6.61M-99.20%4.9M-97.88%6.52M-38.53%318.63M19.83%610.78M17.74%611.82M-40.14%307.69M
Total current liabilities -5.11%6.25B4.09%7.01B2.51%7.21B-7.70%6.58B-8.67%6.58B-14.94%6.74B-18.21%7.03B-18.80%7.13B-16.33%7.21B-8.84%7.92B
Current liabilities
Long term loan 3.75%1.27B7.59%1.32B-12.00%1.28B-28.08%1.12B-10.66%1.22B-14.26%1.22B0.51%1.45B17.63%1.55B-19.34%1.37B-15.92%1.43B
Bonds payable ---------77.77%337.72M-16.79%1.25B-16.79%1.24B-16.77%1.22B4.59%1.52B4.59%1.5B4.59%1.49B4.59%1.47B
Estimate liabilities ----------74.08M--74.08M------------------------
Deferred tax liabilities -7.38%24.25M-5.07%24.13M58.93%28.55M25.96%22.63M53.39%26.18M41.93%25.42M-18.09%17.97M-13.32%17.97M-25.40%17.07M-33.08%17.91M
Long term deferred income -12.39%164.77M-11.44%174.48M-10.61%178.84M-10.23%185.96M-11.52%188.06M-11.89%197.01M-1.61%200.06M-4.22%207.15M-6.61%212.56M-6.15%223.59M
Lease liabilities 59.42%54.41M-2.30%34.82M-7.82%34.04M-9.98%29.15M-8.36%34.13M-8.37%35.64M-5.80%36.92M-13.79%32.38M303.93%37.24M235.31%38.9M
Other non current liabilities ---------------------------------56.57%211.12M-68.07%211.12M
Total non current liabilities -44.13%1.51B-42.68%1.55B-40.15%1.93B-19.14%2.68B-18.75%2.71B-20.17%2.71B-4.35%3.23B2.18%3.31B-13.74%3.34B-16.14%3.39B
Total liabilities -16.49%7.76B-9.31%8.56B-10.91%9.14B-11.33%9.26B-11.86%9.29B-16.51%9.44B-14.30%10.26B-13.14%10.45B-15.53%10.54B-11.15%11.31B
Shareholders equity
Paid-in capital 0.00%1.21B-0.14%1.21B2.33%1.21B0.81%1.21B0.81%1.21B0.95%1.21B-1.52%1.18B0.18%1.2B0.17%1.2B2.51%1.2B
Other equity instruments ---------78.75%91.03M-20.41%340.9M-20.41%340.9M-20.41%340.9M0.00%428.33M0.00%428.33M0.00%428.33M0.00%428.33M
Capital reserve funds 1.90%4.36B-0.27%4.36B9.09%4.35B4.40%4.35B8.05%4.28B22.86%4.37B12.48%3.99B18.58%4.16B14.76%3.96B10.10%3.55B
Surplus reserve funds 7.35%554.12M7.35%554.12M7.35%554.12M7.34%554.12M11.06%516.2M11.06%516.2M11.06%516.2M11.06%516.21M15.72%464.81M15.72%464.81M
Retained profit -2.28%2.5B-3.97%2.42B-12.34%2.23B-14.28%1.98B15.86%2.56B14.76%2.52B16.94%2.54B13.60%2.31B4.99%2.21B17.67%2.19B
Less:Treasury stock 10.92%375.6M22.17%429.31M14.80%400.03M-37.92%341.15M-35.95%338.62M-7.71%351.4M-3.48%348.47M62.72%549.56M121.09%528.71M--380.75M
Other composite income -9.89%11.66M-20.94%11.09M20.94%11.45M12.08%12.17M-0.14%12.94M111.06%14.03M2,111.79%9.47M92.11%10.86M-28.85%12.96M-84.14%6.65M
Shareholders equity without minority interests -3.71%8.25B-5.77%8.12B-3.28%8.04B0.28%8.1B10.76%8.57B15.38%8.61B11.62%8.32B10.62%8.08B5.22%7.74B4.65%7.47B
Minority interests -9.27%242.51M-6.37%246.31M-5.82%245.3M-1.46%247.44M4.61%267.28M570.52%263.06M504.15%260.46M494.63%251.1M107.59%255.5M57.29%39.23M
Total shareholder equity -3.88%8.5B-5.79%8.36B-3.36%8.29B0.23%8.35B10.56%8.84B18.28%8.88B14.45%8.58B13.41%8.33B6.91%7.99B4.84%7.5B
Total liabilityies and equity -10.34%16.26B-7.60%16.93B-7.47%17.43B-6.20%17.61B-2.19%18.13B-2.63%18.32B-3.23%18.84B-3.08%18.78B-7.12%18.54B-5.40%18.81B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion with explanatory notes------Unqualified opinion----
Auditor ------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data